PATENT CLAIM ANALYSIS

Application Number: 16117054
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["424", "203100"]

Abstract:
It was found that bacteria belonging to the genus  Clostridium  induce accumulation of regulatory T cells (Treg cells) in the colon. Moreover, the present inventors found that regulatory T cells (Treg cells) induced by from these bacteria suppressed proliferation of effector T-cells. From these findings, the present inventors found that the use of bacteria belonging to the genus  Clostridium  or a physiologically active substance derived therefrom made it possible to induce proliferation or accumulation of regulatory T cells (Treg cells), and further to suppress immune functions.

Claim (Index 39):
The pharmaceutical composition of  claim 35 , wherein the pharmaceutical composition further comprises one or more bacterial strains belonging to a  Clostridium  cluster other than  Clostridium  cluster IV or  Clostridium  cluster XIVa.

Metadata:
- Claim Count in Document: 134.0
- Percentile: 96.0
- Lexical Diversity: 1.88462
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14492850', '14955630', '15472871', '15216015', '14955532']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8916641690085765
- 35 USC 102 Novelty (BERT): 0.6636195770462606
- Combined Prediction Score: 0.868859709812345
- Mean Citation Score: 780.547722
- Max Citation Score: 794.10065
- Similarity Product: 624.6620963652192

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test